Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments
100% Of Drugs Meta Analyses Reviewed Are Corrupted By Pharma
http://www.sharenews-blog.com:8090/helma/twoday/sharenews/stories/5003/
--------
Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments
http://jama.ama-assn.org/content/305/10/1008.abstract
From Mast Sanity/Mast Network
--------
Beware the ghost(writer)s of medical research
The medical research world has been concerned about the problem of ghostwriting for more than a decade. The issue has been repeatedly raised in the mainstream media over the past few years, with most of the commentary focused on the ethics of academics serving as authors on papers they did not write and on some of the most egregious actions by pharmaceutical companies. But these efforts miss the ways in which Big Pharma has developed new forms of medical research to serve its own interests. Big Pharma firms spend twice as much on promotion as on research and development (R&D). But it is worse than that: more and more medical R&D is organized as promotional campaigns to make physicians aware of products. The bulk of the industry?s external funding for research now goes to contract research organizations to produce studies that feed into large numbers of articles submitted to medical journals. As long as pharmaceutical companies hold the purse strings of medical research, medical knowledge will serve to market drugs, not to promote health. And as long as universities grovel for more partnerships with these companies, the door will remain wide open to proceed with the corruption of scientific research.
Dr Marc-André Gagnon & Dr Sergio Sismondo, EvidenceNetwork.ca, Troy Media
http://www.theoneclickgroup.co.uk/news.php?id=6349#newspost
More about the theme:
http://www.buergerwelle.de:8080/helma/twoday/bwnews/search?q=World+Health+Organi
http://omega.twoday.net/search?q=World+Health+Organi
http://www.sharenews-blog.com:8090/helma/twoday/sharenews/stories/5003/
--------
Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments
http://jama.ama-assn.org/content/305/10/1008.abstract
From Mast Sanity/Mast Network
--------
Beware the ghost(writer)s of medical research
The medical research world has been concerned about the problem of ghostwriting for more than a decade. The issue has been repeatedly raised in the mainstream media over the past few years, with most of the commentary focused on the ethics of academics serving as authors on papers they did not write and on some of the most egregious actions by pharmaceutical companies. But these efforts miss the ways in which Big Pharma has developed new forms of medical research to serve its own interests. Big Pharma firms spend twice as much on promotion as on research and development (R&D). But it is worse than that: more and more medical R&D is organized as promotional campaigns to make physicians aware of products. The bulk of the industry?s external funding for research now goes to contract research organizations to produce studies that feed into large numbers of articles submitted to medical journals. As long as pharmaceutical companies hold the purse strings of medical research, medical knowledge will serve to market drugs, not to promote health. And as long as universities grovel for more partnerships with these companies, the door will remain wide open to proceed with the corruption of scientific research.
Dr Marc-André Gagnon & Dr Sergio Sismondo, EvidenceNetwork.ca, Troy Media
http://www.theoneclickgroup.co.uk/news.php?id=6349#newspost
More about the theme:
http://www.buergerwelle.de:8080/helma/twoday/bwnews/search?q=World+Health+Organi
http://omega.twoday.net/search?q=World+Health+Organi
Starmail - 11. Mär, 17:20
